Sylvain Jacques
6Patents
2h-index
10Co-inventors
40Inventor score
Filing activity: Nov 26, 2013 → Aug 31, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9604937B2 | Pyrimidine-2,4-diamine derivatives for treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US10064869B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Emerging Cross-Sectional Technologies | 2 | Active |
| US10632125B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9944640B2 | Pyrimidine-2,4-diamine derivatives for treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US10179790B2 | MTH1 inhibitors for treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US10174029B2 | Pyrimidine-2,4-diamine derivatives for treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.